It Is Time to Curb the Dogma in Lymphedema Management
Lymphatics · 2023
DOI: 10.3390/lymphatics1030016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lymphatics, 2023. Verfasst von Heather Barnhart. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lymphedema is an under-recognized and underappreciated disease. Advances in imaging and a deeper understanding of the pathophysiology of lymphedema are shedding new light on this disease that affects millions of people worldwide. As new evidence continues to emerge about the microcirculation and revised Starling Principle, etiological factors, related conditions, specific genes, and surgical innovations, the traditional approach to management must also evolve. This evolution is vital to maximize outcomes and improve quality of life. This commentary is a call to action to embrace innovation to better manage lymphedema and expand educational opportunities by leveraging technology to properly train healthcare providers to manage this disease.
Zitieren
APA
Barnhart, H. (2023). It Is Time to Curb the Dogma in Lymphedema Management. Lymphatics. https://doi.org/10.3390/lymphatics1030016
Vancouver
Barnhart H. It Is Time to Curb the Dogma in Lymphedema Management. Lymphatics. 2023. doi:10.3390/lymphatics1030016
BibTeX
@article{Barnhart2023,
author = {Barnhart, Heather},
title = {It Is Time to Curb the Dogma in Lymphedema Management},
journal = {Lymphatics},
year = {2023},
doi = {10.3390/lymphatics1030016}
}
EUVIMED